UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.149

Sortiert nach

Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus

Drug metabolism and disposition, 2008-07, Vol.36 (7), p.1233

2008

Volltextzugriff (PDF)

Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats

Biopharmaceutics & drug disposition, 2006-07, Vol.27 (5), p.209-218

2006

Volltextzugriff (PDF)

Pharmacokinetics of DA-7218, a new oxazolidinone, and its active metabolite, DA-7157, after intravenous and oral administration of DA-7218 and DA-7157 to rats

Journal of pharmacy and pharmacology, 2007-07, Vol.59 (7), p.955-963

2007

Volltextzugriff (PDF)

Pharmacokinetics of DA-7867, a New Oxazolidinone, after Intravenous or Oral Administration to Rats: Intestinal First-Pass Effect

Antimicrobial Agents and Chemotherapy, 2004-02, Vol.48 (2), p.659-662

2004

Volltextzugriff (PDF)

Effect of hepatic CYP inhibitors on the metabolism of sildenafil and formation of its metabolite, N-desmethylsildenafil, in rats in vitro and in vivo

Journal of pharmacy and pharmacology, 2009-12, Vol.61 (12), p.1637-1642

2009

Volltextzugriff (PDF)

Pharmacokinetics of sildenafil after intravenous and oral administration in rats: Hepatic and intestinal first-pass effects

International journal of pharmaceutics, 2006-08, Vol.320 (1), p.64-70

2006

Volltextzugriff (PDF)

Pharmacokinetics of intravenous methotrexate in mutant Nagase analbuminemic rats

Biopharmaceutics & drug disposition, 2007-10, Vol.28 (7), p.385-392

2007

Volltextzugriff (PDF)

Pharmacokinetics of Amitriptyline and One of Its Metabolites, Nortriptyline, in Rats: Little Contribution of Considerable Hepatic First-Pass Effect to Low Bioavailability of Amitriptyline Due to Great Intestinal First-Pass Effect

Journal of pharmaceutical sciences, 2009-04, Vol.98 (4), p.1587-1601

2009

Volltextzugriff (PDF)

Pharmacokinetics of Chlorzoxazone in Rats with Diabetes: Induction of CYP2E1 on 6-Hydroxychlorzoxazone Formation

Journal of pharmaceutical sciences, 2006-11, Vol.95 (11), p.2452-2462

2006

Volltextzugriff (PDF)

Pharmacokinetics and Therapeutic Effects of Oltipraz after Consecutive or Intermittent Oral Administration in Rats with Liver Cirrhosis Induced by Dimethylnitrosamine

Journal of pharmaceutical sciences, 2006-05, Vol.95 (5), p.985-997

2006

Volltextzugriff (PDF)

Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine

International journal of pharmaceutics, 2004-05, Vol.275 (1), p.227-238

2004

Volltextzugriff (PDF)

Pharmacokinetics of Oltipraz in Mutant Nagase Analbuminemic Rats

Journal of pharmaceutical sciences, 2006-05, Vol.95 (5), p.998-1005

2006

Volltextzugriff (PDF)

Pharmacokinetics of 5-fluorouracil in mutant Nagase analbuminemic rats: faster metabolism of 5-fluorouracil via CYP1A

Biopharmaceutics & drug disposition, 2007-03, Vol.28 (2), p.87-95

2007

Volltextzugriff (PDF)

Effects of cysteine on the pharmacokinetics of oltipraz in rats with protein–calorie malnutrition

Journal of pharmaceutical sciences, 2005-07, Vol.94 (7), p.1484-1493

2005

Volltextzugriff (PDF)

Effects of cysteine on the pharmacokinetics of intravenous torasemide in rats with protein−calorie malnutrition

Journal of pharmaceutical sciences, 2004-09, Vol.93 (9), p.2388-2398

2004

Volltextzugriff (PDF)

Effects of acute renal failure on the pharmacokinetics of oltipraz in rats

Journal of pharmaceutical sciences, 2004-09, Vol.93 (9), p.2353-2363

2004

Volltextzugriff (PDF)

Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin

European journal of pharmaceutical sciences, 2005-06, Vol.25 (2), p.337-345

2005

Volltextzugriff (PDF)

Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3-dimethyluric acid, after intravenous and oral administration of aminophylline to rats

Biopharmaceutics & drug disposition, 2007-11, Vol.28 (8), p.445-454

2007

Volltextzugriff (PDF)

Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics

Biopharmaceutics & drug disposition, 2005-04, Vol.26 (3), p.99-115

2005

Volltextzugriff (PDF)

Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats

Journal of pharmaceutical sciences, 2004-09, Vol.93 (9), p.2364-2373

2004

Volltextzugriff (PDF)

Hepatic and intestinal first-pass effects of oltipraz in rats

Biopharmaceutics & drug disposition, 2005-05, Vol.26 (4), p.129-134

2005

Volltextzugriff (PDF)

Pharmacokinetics of 5-fluorouracil in rats with diabetes mellitus induced by streptozotocin

Biopharmaceutics & drug disposition, 2005-04, Vol.26 (3), p.93-98

2005

Volltextzugriff (PDF)

Pharmacokinetics of oltipraz after intravenous and oral administration in rats with dehydration for 72 hours

Biopharmaceutics & drug disposition, 2005-03, Vol.26 (2), p.77-83

2005

Volltextzugriff (PDF)

Effects of water deprivation for 72 hours on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats

Biopharmaceutics & drug disposition, 2006-04, Vol.27 (3), p.147-156

2006

Volltextzugriff (PDF)

Excretion and Metabolism of DA-7867, a New Oxazolidinone, in Rats

Biopharmaceutics & drug disposition, 2005-03, Vol.26 (2), p.67-75

2005

Volltextzugriff (PDF)

1 – 25 von 1.149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.082)
Mit Volltextzugriff
(1.056)

Publikationsform

Sprache

Englisch
(1.134)
Japanisch
(204)
Koreanisch
(14)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus

Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats

Pharmacokinetics of DA-7218, a new oxazolidinone, and its active metabolite, DA-7157, after intravenous and oral administration of DA-7218 and DA-7157 to rats

Pharmacokinetics of DA-7867, a New Oxazolidinone, after Intravenous or Oral Administration to Rats: Intestinal First-Pass Effect

Effect of hepatic CYP inhibitors on the metabolism of sildenafil and formation of its metabolite, N-desmethylsildenafil, in rats in vitro and in vivo

Pharmacokinetics of sildenafil after intravenous and oral administration in rats: Hepatic and intestinal first-pass effects

Pharmacokinetics of intravenous methotrexate in mutant Nagase analbuminemic rats

Pharmacokinetics of Amitriptyline and One of Its Metabolites, Nortriptyline, in Rats: Little Contribution of Considerable Hepatic First-Pass Effect to Low Bioavailability of Amitriptyline Due to Great Intestinal First-Pass Effect

Pharmacokinetics of Chlorzoxazone in Rats with Diabetes: Induction of CYP2E1 on 6-Hydroxychlorzoxazone Formation

Pharmacokinetics and Therapeutic Effects of Oltipraz after Consecutive or Intermittent Oral Administration in Rats with Liver Cirrhosis Induced by Dimethylnitrosamine

Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine

Pharmacokinetics of Oltipraz in Mutant Nagase Analbuminemic Rats

Pharmacokinetics of 5-fluorouracil in mutant Nagase analbuminemic rats: faster metabolism of 5-fluorouracil via CYP1A

Effects of cysteine on the pharmacokinetics of oltipraz in rats with protein–calorie malnutrition

Effects of cysteine on the pharmacokinetics of intravenous torasemide in rats with protein−calorie malnutrition

Effects of acute renal failure on the pharmacokinetics of oltipraz in rats

Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin

Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3-dimethyluric acid, after intravenous and oral administration of aminophylline to rats

Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics

Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats

Hepatic and intestinal first-pass effects of oltipraz in rats

Pharmacokinetics of 5-fluorouracil in rats with diabetes mellitus induced by streptozotocin

Pharmacokinetics of oltipraz after intravenous and oral administration in rats with dehydration for 72 hours

Effects of water deprivation for 72 hours on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats

Excretion and Metabolism of DA-7867, a New Oxazolidinone, in Rats

Suchergebnisse filtern